Sangamo Therapeutics, Inc.

Rachunek Zysków i Strat





Przychody TTM (mln): 52
EBIT TTM (mln): -133
index 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25
Rok finansowy 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Przychód (mln) 2 3 5 4 3 1 2 8 9 16 22 21 10 22 24 46 40 19 37 84 102 118 111 111 176 58
Przychód Δ r/r 0.0% 56.0% 42.3% -11.1% -40.6% -49.0% 88.9% 217.4% 15.4% 77.9% 37.1% -6.2% -50.4% 109.9% 11.4% 90.1% -13.8% -51.0% 88.6% 131.0% 21.3% 15.4% -6.3% 0.5% 58.3% -67.2%
Marża brutto 131.8% 252.4% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% -42.5% -52.8% 91.5% 89.1% 87.4% 100.0%
EBIT (mln) -4 -12 -28 -32 -12 -15 -14 -21 -25 -25 -19 -25 -36 -22 -27 -27 -47 -73 -56 -77 -105 -130 -183 -201 -114 -104
EBIT Δ r/r 0.0% 220.1% 127.8% 11.0% -62.7% 24.5% -6.2% 50.8% 19.5% 2.4% -23.5% 28.5% 43.7% -38.0% 20.3% 0.3% 75.0% 54.9% -22.3% 36.9% 36.3% 23.2% 41.5% 9.8% -43.2% -9.0%
EBIT (%) -177.3% -363.6% -582.2% -726.8% -456.3% -1114.1% -553.5% -262.9% -272.3% -156.8% -87.4% -119.9% -347.1% -102.5% -110.7% -58.4% -118.5% -374.2% -154.1% -91.4% -102.7% -109.6% -165.6% -180.8% -64.9% -179.9%
Koszty finansowe (mln) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 -9 0 0
EBITDA (mln) -3 -7 2 -11 -10 -13 -13 -21 -25 -24 -19 -25 -36 -22 -27 -26 -47 -73 -56 -77 -105 -130 -183 -201 -92 -89
EBITDA(%) -145.5% -211.2% 40.8% -247.2% -372.8% -1017.6% -505.8% -268.6% -273.1% -146.4% -86.1% -119.9% -347.1% -102.5% -110.2% -57.4% -118.5% -374.2% -154.1% -91.4% -102.7% -109.6% -165.6% -180.8% -52.3% -154.1%
Podatek (mln) -0 -3 10 -1 -1 -1 -0 -2 -1 -1 -1 -1 -1 -1 -1 -1 -6 -0 -1 8 -20 0 0 0 -5 -0
Zysk Netto (mln) -4 -9 -25 -30 -10 -14 -13 -18 -21 -24 -19 -25 -36 -22 -27 -26 -41 -72 -55 -68 -76 -121 -178 -192 -258 -98
Zysk netto Δ r/r 0.0% 138.6% 178.5% 17.9% -64.9% 32.4% -3.8% 34.4% 20.2% 13.1% -23.5% 33.7% 43.8% -37.7% 19.6% -0.8% 54.1% 76.1% -23.8% 25.2% 11.0% 59.8% 47.2% 7.8% 34.1% -62.0%
Zysk netto (%) -172.7% -264.1% -516.9% -685.3% -404.5% -1050.8% -535.1% -226.6% -236.1% -150.1% -83.8% -119.5% -346.4% -102.8% -110.3% -57.6% -102.9% -369.6% -149.2% -80.9% -74.0% -102.5% -161.1% -172.8% -146.3% -169.4%
EPS -0.63 -0.52 -1.09 -1.22 -0.42 -0.55 -0.51 -0.55 -0.58 -0.6 -0.44 -0.55 -0.71 -0.42 -0.48 -0.39 -0.58 -1.02 -0.7 -0.7 -0.68 -0.9 -1.23 -1.25 -1.48 -0.49
EPS (rozwodnione) -0.63 -0.52 -1.09 -1.22 -0.42 -0.55 -0.51 -0.55 -0.58 -0.6 -0.44 -0.55 -0.71 -0.42 -0.48 -0.39 -0.58 -1.02 -0.7 -0.7 -0.68 -0.9 -1.23 -1.25 -1.48 -0.49
Ilośc akcji (mln) 6 17 23 24 25 25 26 33 37 41 42 45 51 53 56 67 70 71 78 97 112 134 145 154 174 202
Ważona ilośc akcji (mln) 6 17 23 24 25 25 26 33 37 41 42 45 51 53 56 67 70 71 78 97 112 134 145 154 174 202
Waluta USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD USD